CyberKnife Treatments

CyberKnife® Treatments

The list below shows a very brief summary of treatments offered, however it must be stressed that not all cases are suitable for CyberKnife radiosurgery and some centres do not offer all treatments. The list is based on current information but is subject to revision from time to time.

Acoustic neuroma (vestibular schwannoma), meningeoma, haemangioblastoma, jugular foramens tumour, other neuromas, metastases, AVM (ateriovenous malformation), trigeminal neuralgia, uveal melanoma

Certain tumours to the lung, liver, pancreas and prostate. Note that some of these treatments require a multi-modal approach and that CyberKnife alone may not be sufficient. Patients with these conditions usually need detailed reports from their doctor to make effective applications.

Metastases, neuromas, meningeomas, haemangioblastomas, MPNST (malignant peripheral nerve sheath tumour).

Further details of these treatments may be found on the manufacturer‘s websites www.cyberknife.com and www.accuray.com. Please note that MHL is not responsible for any content on those web sites.

Advanced treatment centres

Latest medical technologies

Private medical centres

Is CyberKnife clinically proven?

The internet retains many old pages, which can be long out of date. Also because CyberKnife is not yet available in some countries or is still new there, some doctors and medical charities are not yet familiar with it or are unaware of how well established it has become in the rest of the world.

How does CyberKnife® differ from GammaKnife®?

It is also approved in Canada, the European Union, Switzerland, Japan, Taiwan and many other countries. Many clinical studies have been published in medical journals, thousands of patients have received treatment and there are now 160 systems installed worldwide.

I read somewhere that CyberKnife is 'experimental'?

As with any medical technology, CyberKnife had to pass through a phase when individual treatments were regarded as 'experimental'. The different organs of the body also require their own special treatment protocols, so as new protocols are developed there is necessarily an 'experimental' element, whilst other treatments are already well established.

The CyberKnife system is based on radiation technology that has been proven for 30 years and in 2001 it received FDA (the US medical regulatory body) clearance for treatment of tumours anywhere in the body where radiation was indicated.

GammaKnife is is not a full body treatment. It has advantages in some respects but it can only provide intracranial treatments and requires an intrusive head frame to be screwed into the skull, which CyberKnife does not require.

You can find further details on the differences between these two systems on our dedicated website www.cyberknifeservice.com. The surgeons at some centres (e.g. Munich and Zurich) have chosen to stop offering GammaKnife treatments once CyberKnife is operational.

Brain and eye

Spine

Body

Body tumours are treated using the Sychrony software (left) which allows the CyberKnife to track soft tissue tumors, compensating for natural movement due to breathing and which has extended the range of treatments that can be offered.

Small metal markers ('fiducials') are implanted near the tumour and must be allowed to settle for a few days before treatment. They are usually not required for brain and spine treatments however since many CyberKnife Centres now use the 'X-Sight' software which allows the CyberKnife to use the patient's own bone structure to provide the necessary markers.

Tumours are tracked to follow breathing motion.

Click to enlarge

Specialist treatments < CyberKnife radiosurgery < Treatments

MHL international web sites

MHL Danmark
mediluxhealthcare.dk

Web sites in 30 countries

Click map for details